Payden & Rygel Pfizer Inc Transaction History
Payden & Rygel
- $1.3 Billion
- Q3 2024
A detailed history of Payden & Rygel transactions in Pfizer Inc stock. As of the latest transaction made, Payden & Rygel holds 313,980 shares of PFE stock, worth $8.39 Million. This represents 0.7% of its overall portfolio holdings.
Number of Shares
313,980
Previous 29,980
947.3%
Holding current value
$8.39 Million
Previous $839,000
983.08%
% of portfolio
0.7%
Previous 0.07%
Shares
23 transactions
Others Institutions Holding PFE
# of Institutions
3,260Shares Held
3.73BCall Options Held
73.5MPut Options Held
108M-
Vanguard Group Inc Valley Forge, PA511MShares$13.7 Billion0.28% of portfolio
-
Black Rock Inc. New York, NY424MShares$11.3 Billion0.27% of portfolio
-
State Street Corp Boston, MA287MShares$7.67 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA166MShares$4.44 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA117MShares$3.13 Billion0.63% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $150B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...